
Adenoid Cystic Carcinoma (ACC) is a rare cancer found in most cases within the salivary glands. However, it is also able to be found elsewhere in the body including the female breast/right atrium/breast/mammary gland, respiratory transitions, vagina, and female anatomy. Adenoid cystic carcinoma is a slowly growing cancer that tends to spread along nerves aggressively.
Causes
Risk Factors
In the United Arab Emirates, the advanced incorporation of diagnostics, targeted therapies, and minimally invasive surgical methods has completely transformed the management of Adenoid Cystic Carcinoma (ACC). Timely detection by imaging modalities and prognostication through molecular profile analysis provides a unique treatment modality for each patient. Precision-based radiotherapy, including proton beam therapy and IMRT, is applied to spare surrounding tissues. Trials for immunotherapy and clinical trials for inhibitors are currently being conducted.
The medical treatment for Adenoid Cystic Carcinoma requires evaluating the patient's severity and medical condition. The following are the treatment options:
Surgical Management: Surgery is usually the primary modality in treating Adenoid Cystic Carcinoma (ACC). The goal is to completely resect the tumour with clear margins. Wide local excision is standard for tumours in the head and neck or salivary glands.
Radiation therapy: When surgery cannot altogether remove the tumor or if there is a high risk for recurrence, most likely, it will be radiation therapy afterwards. These are advanced radiation techniques; two examples are IMRT and proton therapy. This has the least effect on the surroundings.
Chemotherapy : ACCs usually respond poorly to standard chemotherapy drugs, so their use is discouraged in such cases. In exceptional cases with metastatic or advanced disease, or when surgery and radiotherapy are not good options or not possible in that situation, chemotherapy might be attempted.
Cost Start From USD 800 - USD 6000Explore Options
Targeted Therapy: It is an emerging therapy that targets the selected molecular mutations in ACC. Tyrosine kinase inhibitors are in the pretesting stages, but they are helpful in researching the treatment possibilities of advanced cases.
Cost Start From USD 5500 - USD 54000Explore Options
Immunotherapy : ACC immunological research concerns the immune checkpoint blockade, especially in the more advanced stages. For advanced and relapsing cases, palliative care focuses more on symptom management and quality of life improvement.
{immunotherapy}These are the standard diagnostic methods for diagnosing Adenoid Cystic Carcinoma:
Clinical Assessment
Biopsy
MediRehab (a chain of Rehab centres, part of MediGence) provides comprehensive rehabilitation services to support patients through Teleconsulations and online therapy sessions.
Treatment options for Adenoid Cystic Carcinoma (ACC) may often include chemotherapy. Still, it has been known to be less successful. However, there are emerging and targeted forms of therapy through tyrosine kinase inhibitors versus other phenomena that involve immunotherapy via immune checkpoint inhibitors for advanced stages.









Dubai, United Arab Emirates

Sharjah, United Arab Emirates

Abu Dhabi, United Arab Emirates
The Hospital owns an International Patient Services Team that is responsible to assist international patients with world-class healthcare, transportation arrangement, accommodation facilities, language interpreters, and much more.
Burjeel Medical City (about 1.2 million square facilities)provides 7-star hospitality to its patients. It has the largest facility space bed among all the private hospitals. The Hospital consists of-
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
ACC is a treatable but not easily curable cancer. If diagnosed early and treated appropriately, there is a good chance of managing the disease, but recurrence is common due to its slow-growing nature. Long-term follow-up is essential.
The prognosis for ACC depends on the tumour’s location, stage, and whether it has spread. With early detection and treatment, the survival rate is relatively good, but the disease’s tendency to recur or spread makes regular monitoring important.
While slow-growing, ACC can spread to other areas, particularly the lungs, bones, and liver. If the cancer metastasises, it becomes harder to treat, but not impossible.
There are no known methods to prevent ACC. However, reducing exposure to radiation and avoiding smoking may lower the risk of developing certain cancers, including ACC.

Dr. Shagufta Parveen is a Clinical researcher and medical writer with expertise in clinical pharmacology and pharmacotherapeutics. She holds a B.Pharm and Doctor of Pharmacy (Post-Baccalaureate) degree from Teerthanker Mahaveer University, Moradabad.
During her clinical stint at BLK-Max Super Speciality Hospital and Indraprastha Apollo Hospital, she gained hands-on experience in the Clinical Pharmacology Department. Combining scientific knowledge with strong medical writing skills, Dr. Shagufta develops evidence-based healthcare content, treatment guides, and patient education resources.
Her work focuses on simplifying complex medical concepts while maintaining scientific accuracy, helping readers better understand healthcare advancements and treatment options.
In addition to her writing expertise, she is actively involved in scientific research and has contributed to peer-reviewed publications.
Her research work is accessible through the following links:
https://scholar.google.com/citations?user=lMVK1eIAAAAJ&hl=en
https://carcinogenesis.com/index.php/JOC/article/view/870
https://carcinogenesis.com/index.php/JOC/article/view/868
https://wjpsronline.com/abstract/0000000760
View More
Medical Oncologist
14 Years of Experience
One of the finest Oncologist in New Delhi, India, Dr. Mohit Agarwal has worked with several world class multidisciplinary hospitals over the years. Dr. Mohit Agarwal has over 14+ years of experience in his field. The doctor treats and manages a wide range of conditions such as Stomach Cancer, Rectal Cancer, Breast Cancer, Brain Cancer View More
Last Reviewed - January 2026